United States - English - NLM (National Library of Medicine)

general injectables & vaccines, inc - bupivacaine hydrochloride (unii: 7tqo7w3vt8) (bupivacaine - unii:y8335394ro) - bupivacaine hydrochloride anhydrous 2.5 mg in 1 ml - marcaine / marcaine with epinephrine is indicated in adults for the production of local or regional anesthesia or analgesia for surgery, dental and oral surgery procedures, diagnostic and therapeutic procedures, and for obstetrical procedures. specific concentrations and presentations of marcaine / marcaine with epinephrine are recommended for each type of block indicated to produce local or regional anesthesia or analgesia [see dosage and administration (2.2)]. limitations of use not all blocks are indicated for use with marcaine / marcaine with epinephrine given clinically significant risks associated with use [see dosage and administration (2.2), contraindications (4), warnings and precautions (5.1, 5.4, 5.5, 5.7, 5.9)]. marcaine / marcaine with epinephrine is contraindicated in: - obstetrical paracervical block anesthesia. its use in this technique has resulted in fetal bradycardia and death. - intravenous regional anesthesia (bier block) [see warnings and precautions (5.7)]. - patients with a known hyper

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - bupivacaine hydrochloride monohydrate, quantity: 2.64 mg/ml (equivalent: bupivacaine hydrochloride, qty 2.5 mg/ml) - injection, solution - excipient ingredients: sodium chloride; sodium hydroxide; water for injections - surgical anaethesia. epidural block for surgery. field block (minor & major nerve block & infiltration. analgesia. continuous epidural infusion or intermittent bolus administration for analgesia in post operative or labour pain. field block (minor nerve block & infiltration).

United States - English - NLM (National Library of Medicine)

general injectables & vaccines, inc - bupivacaine hydrochloride (unii: 7tqo7w3vt8) (bupivacaine - unii:y8335394ro) - bupivacaine hydrochloride 5 mg in 1 ml - sensorcaine (bupivacaine hcl) is indicated for the production of local or regional anesthesia or analgesia for surgery, dental and oral surgery procedures, diagnostic and therapeutic procedures, and for obstetrical procedures. only the 0.25% and 0.5% concentrations are indicated for obstetrical anesthesia (see warnings). experience with nonobstetrical surgical procedures in pregnant patients is not sufficient to recommend use of the 0.75% concentration of bupivacaine hcl in these patients. sensorcaine is not recommended for intravenous regional anesthesia (bier block) (see warnings). the routes of administration and indicated sensorcaine concentrations are: standard textbooks should be consulted to determine the accepted procedures and techniques for the administration of sensorcaine. sensorcaine (bupivacaine hcl) is contraindicated in obstetrical paracervical block anesthesia. its use in this technique has resulted in fetal bradycardia and death. sensorcaine is contraindicated in patients with a known hypers

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

0.25%) / adrenaline (base) 50micrograms/10ml (1 in 200,000) solution for injection ampoules (advanz pharma - bupivacaine hydrochloride; adrenaline acid tartrate - solution for injection - 2.5mg/1ml ; 5microgram/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

0.5%) / adrenaline (base) 50micrograms/10ml (1 in 200,000) solution for injection ampoules (advanz pharma - bupivacaine hydrochloride; adrenaline acid tartrate - solution for injection - 5mg/1ml ; 5microgram/1ml

United States - English - NLM (National Library of Medicine)

general injectables & vaccines, inc - bupivacaine hydrochloride (unii: 7tqo7w3vt8) (bupivacaine - unii:y8335394ro) - bupivacaine hydrochloride 2.5 mg in 1 ml - sensorcaine (bupivacaine hcl) is indicated for the production of local or regional anesthesia or analgesia for surgery, oral surgery procedures, diagnostic and therapeutic procedures, and for obstetrical procedures. only the 0.25% and 0.5% concentrations are indicated for obstetrical anesthesia (see warnings). experience with non-obstetrical surgical procedures in pregnant patients is not sufficient to recommend use of the 0.75% concentration of bupivacaine hcl in these patients. sensorcaine is not recommended for intravenous regional anesthesia (bier block) (see warnings). the routes of administration and indicated sensorcaine concentrations are: local infiltration 0.25% peripheral nerve block 0.25%, 0.5% retrobulbar block 0.75% sympathetic block 0.25% lumbar epidural 0.25%, 0.5% and 0.75% (non-obstetrical) caudal 0.25%, 0.5% epidural test dose (see precautions) (see dosage and administration for additional information). standard textbooks should be consulted to determine the accepted procedure

United States - English - NLM (National Library of Medicine)

asclemed usa, inc. - lidocaine hydrochloride (unii: v13007z41a) (lidocaine - unii:98pi200987) - lidocaine hydrochloride anhydrous 10 mg in 1 ml - bupivacaine hydrochloride injection is indicated in adults for the production of local or regional anesthesia or analgesia for surgery, dental and oral surgery procedures, diagnostic and therapeutic procedures, and for obstetrical procedures. specific concentrations and presentations of bupivacaine hydrochloride injection are recommended for each type of block indicated to produce local or regional anesthesia or analgesia [see dosage and administration (2.2)]. limitations of use not all blocks are indicated for use with bupivacaine hydrochloride injection given clinically significant risks associated with use [see dosage and administration (2.2), contraindications (4), warnings and precautions (5.1, 5.4, 5.5, 5.7, 5.9)] . bupivacaine hydrochloride injection/bupivacaine hydrochloride and epinephrine injection is contraindicated

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

unimed sdn bhd - bupivacaine hydrochloride -

United States - English - NLM (National Library of Medicine)

astrazeneca lp - bupivacaine hydrochloride (unii: 7tqo7w3vt8) (bupivacaine - unii:y8335394ro) - injection - 2.5 mg in 1 ml - sensorcaine (bupivacaine hcl) is indicated for the production of local or regional anesthesia or analgesia for surgery, for oral surgery procedures, for diagnostic and therapeutic procedures, and for obstetrical procedures. only the 0.25% and 0.5% concentrations are indicated for obstetrical anesthesia. (see warnings.) experience with non-obstetrical surgical procedures in pregnant patients is not sufficient to recommend use of the 0.75% concentration in these patients. sensorcaine is not recommended for intravenous regional anesthesia (bier block). (see warnings.) the routes of administration and indicated sensorcaine concentrations are: local infiltration 0.25% peripheral nerve block 0.25%, 0.5% retrobulbar block 0.75% sympathetic block 0.25% lumbar epidural 0.25%, 0.5% and 0.75% (non-obstetrical) caudal 0.25%, 0.5% epidural test dose (see precautions) (see dosage and administration for additional information.) standard textbooks should be consulted to determine the accepted procedures and techniques for th

United States - English - NLM (National Library of Medicine)

prescription care llc - bupivacaine hydrochloride (unii: 7tqo7w3vt8) (bupivacaine - unii:y8335394ro), ketorolac tromethamine (unii: 4eve5946bq) (ketorolac - unii:yzi5105v0l), chitosan low molecular weight (20-200 mpa.s) (unii: sbd1a2i75n) (chitosan low molecular weight (20-200 mpa.s) - unii:sbd1a2i75n) - bupivacaine hydrochloride anhydrous 0.09 g in 30 ml